Dr Simon Holzer > MLL Legal > Zurich, Switzerland > Lawyer Profile

Focusing on high-tech, innovative and regulated sectors, MLL Legal excels in the field of distribution law, operating for clients across vertical agreements and questions relating to dominance. ‘Extremely dedicated’ Renato Bucher and Hubert Orso Gilliéron, who is praised for his ‘extensive knowledge’ and being ‘quick on his feet’, jointly helm the practice. Simon Holzer is adept at handling mandates that incorporate aspects of competition and IP issues.

Possessing a ‘profound knowledge of IP law’, MLL Legal’s IP offering encompasses the full scope of litigation, arbitration and strategic advice within the sphere of IP. While esteemed for its considerable expertise in patent litigation and counterfeit cases, the team is also noted for its operations in precedent-setting blockchain matters. Michael Ritscher, Simon Holzer and Peter Schramm spearhead the IP practice, with Holzer thriving in complex patent litigation and transactional work and Schramm being an established presence within the trade mark and design world. Louisa Galbraith is also recommended.

MLL Legal’s practice group has extensive experience in the production and distribution of a range of regulated products, including pharmaceuticals, medical products, tobacco and cosmetics. The team regularly advises and represents clients on all public procurement matters. The team is co-headed by Simon Holzer, who has extensive expertise in the pharmaceutical sector, and Michael Reinle, who advises clients in the software, IT, and telecoms industries. Kilian Schärli has a special focus on blockchain pharmaceutical use cases and transactions in the life sciences sector. Daniel Donauer, who was promoted to senior associate in 2023, has expertise in the implementation and regulation of cosmetics, alcohol, tobacco and therapeutic products.

Jointly led by Nicola Benz and the ‘very smart, very strategic‘ Simon Holzer, the Zurich based team at MLL Legal acts for universities and pharma companies in matters involving the drafting and negotiation of clinical trial and cooperation agreements, pricing disputes, and the use of blockchain within a pharma context. Benz primarily advises technology companies, investors, and suppliers on outsourcing and collaboration related issues within the life sciences sector. IP litigator Holzer is well known for his broad expertise in matters involving FRAND cases and standard essential patents, with the pharma industry being his key area of focus. Ulrike Ciesla has vast experience in handling patent prosecution and appeal proceedings, while Louisa Galbraith is well versed in mandates concerning unfair competition and trade marks.